series-c-plus
Stage
3
Investors
About
ADARx Pharmaceuticals is a clinical-stage biotechnology company developing RNA-based therapeutics with proprietary RNA science and targeted delivery platforms, focusing on diseases including renal, hematologic, metabolic, and neurodegenerative conditions.
Explore ADARx Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.